High neutralizing potency of swine glyco‐humanized polyclonal antibodies against SARS‐CoV‐2

Heterologous polyclonal antibodies might represent an alternative to the use of convalescent plasma or monoclonal antibodies (mAbs) in coronavirus disease (COVID‐19) by targeting multiple antigen epitopes. However, heterologous antibodies trigger human natural xenogeneic antibody responses particula...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Τόπος έκδοσης:Eur J Immunol
Κύριοι συγγραφείς: Vanhove, Bernard, Duvaux, Odile, Rousse, Juliette, Royer, Pierre‐Joseph, Evanno, Gwénaëlle, Ciron, Carine, Lheriteau, Elsa, Vacher, Laurent, Gervois, Nadine, Oger, Romain, Jacques, Yannick, Conchon, Sophie, Salama, Apolline, Duchi, Roberto, Lagutina, Irina, Perota, Andrea, Delahaut, Philippe, Ledure, Matthieu, Paulus, Melody, So, Ray T., Mok, Chris Ka‐Pun, Bruzzone, Roberto, Bouillet, Marc, Brouard, Sophie, Cozzi, Emanuele, Galli, Cesare, Blanchard, Dominique, Bach, Jean‐Marie, Soulillou, Jean‐Paul
Μορφή: Artigo
Γλώσσα:Inglês
Έκδοση: John Wiley and Sons Inc. 2021
Θέματα:
Immunity to infection
Διαθέσιμο Online:https://ncbi.nlm.nih.gov/pmc/articles/PMC8014652/
https://ncbi.nlm.nih.gov/pubmed/33576494
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/eji.202049072
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια